Arvinas (ARVN) Net Shares Issued and Repurchased (2017 - 2021)
Analysis
Arvinas (ARVN) Net Shares Issued and Repurchased (2017 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.56 Bn | 58.37 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.22 Bn | 53.09 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.18 Bn | 44.18 Bn | - | - |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.31 Bn | 32.00 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | - |
| 10 | Arvinas | 610.09 Mn | 42.19 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 1.30 Mn |
| Dec 31, 2020 | 1.42 Mn |
| Mar 31, 2020 | 1.09 Mn |
| Dec 31, 2019 | 1.52 Mn |
| Mar 31, 2019 | 1.05 Mn |
| Dec 31, 2018 | 34,982.00 |
| Sep 30, 2018 | 2.00 Mn |
| Dec 31, 2017 | 547,616.00 |